We are using the genetic model organism, C. elegans, do investigate the genetic basis of both normal and disordered behaviour. Our current interests are identifying the genes responsible for anxiety and depression as well as the genes for eating disoders and addiction. Using C. elegans as a model organism will also allow us to study gene function as it relates to behaviour.
Molecular mechanisms of phosphine resistance (other research)
Genetic mapping of oxidative stress resistance genes. The fumigant phosphine disrupts oxidative metabolism, resulting in the production of reactive oxygen intermediates. This causes the premature ageing and death of targeted pests. Insect pests of stored grain in Australia now exhibit resistance to phosphine at levels more than 200 times the normal lethal dose.
We have genetically mappedf and identified the genes responsible for phosphine resistance in tall major insect pests of stored grain. We are using a systems biology approach in the model organism C. elegans to understand the molecular basis of phosphine action. Our genetic studies have recently shown that resistance to phosphine is associated with an extension of lifespan
Dr Daniel Sullivan is a Psychologist and Research Fellow at the UQ Poche Centre for Indigenous Health as a member of the Let's Yarn About Sleep team. He also maintains a clinical appointment as a Senior Psychologist (Sleep Disorders) in the public sector, where he is leading a project to develop an expanded scope of practice model of care in Sleep Psychology. Prior to qualifying as a Psychologist, Dr Sullivan worked clinically as a Sleep Technologist for over 5 years across the private and public sectors. Dr Sullivan completed his PhD in Clinical Psychology at Griffith University, and MSc in Sleep Medicine at the University of Sydney.
Princess Alexandra Hospital Southside Clinical Unit
Faculty of Medicine
Availability:
Available for supervision
Tim is a clinical pharmacist and conjoint lecturer working at the School of Pharmacy and the Princess Alexandra Hospital. He graduated from the Bachelor of Pharmacy at the University of Queensland in 2014. After working in mental health at the Princess Alexandra Hospital, he become interested in schizophrenia and psychopharmacology. He began his PhD with the School of Clinical Medicine in 2020 and his research interests include clozapine, treatment refractory schizophrenia, and the safe use of antipsychotic medicines. He is the team leader of mental health pharmacy at the Princess Alexandra Hospital. Tim teaches into the Bachelor of Pharmacy and the Masters of Clinical Pharmacy programs at the University of Queensland, and supervises research project placements.
